H.C. Wainwright Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)
at www.tipranks.com (Thu, 1-Oct 6:35 AM)
TLSI climbs after FDA clears TriNav Advance, adding distal-vessel access to its PEDD liver embolization toolkit
Market Chameleon (Wed, 23-Sep 10:31 AM)
TriSalus Wins FDA 510(k) Clearance for TriNav Advance, Adding Small-Vessel Access to Its PEDD Portfolio
Market Chameleon (Wed, 23-Sep 7:06 AM)
